Trade Summary

7 months ago, Mosseri Marlio Charles, serving as 10% owner at Nuvectis Pharma, Inc. (NVCT), purchased 154,770 shares at $6.18 per share, for a total transaction value of $957,083.00. Following this transaction, Mosseri Marlio Charles now holds 3,245,897 shares of NVCT.

This purchase represents a 5.00% increase in Mosseri Marlio Charles's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, October 23, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, October 29, 2025 at 4:00 AM ET, 6 days after the trade was made.

Nuvectis Pharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.